Eventide Asset Management’s Zimmer Biomet ZBH Stock Holding History

Eventide Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,827	Closed	-$3.24M	–	164
2021 Q1	$3.24M	Hold	20,827	–	–	0.05%	141
2020 Q4	$3.12M	Sell	20,827 -7,807	-27%	-$1.1M	0.05%	135
2020 Q3	$3.79M	Buy	28,634 +6,798	+31%	+$888K	0.07%	120
2020 Q2	$2.53M	Buy	21,836 +6,180	+39%	+$712K	0.06%	122
2020 Q1	$1.54M	Buy	15,656 +4,120	+36%	+$540K	0.05%	115
2019 Q4	$1.68M	Buy	+11,536	New	+$1.59M	0.05%	102

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Eventide Asset Management's ZBH Position: Q2 2021 in Review

Eventide Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 20,827 shares — an estimated $3.24M sold.

Eventide Asset Management first reported a position in ZBH in Q4 2019 and held it in 6 quarters. The position peaked at $3.79M in Q3 2020. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

Eventide Asset Management reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
Eventide Asset Management sold 20,827 Zimmer Biomet shares in Q2 2021, an estimated $3.24M.
Eventide Asset Management first reported a position in Zimmer Biomet in Q4 2019 and held it in 6 quarters.
Eventide Asset Management's Zimmer Biomet position peaked at $3.79M in Q3 2020.
1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Eventide Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.